Au cours de ces travaux nous nous sommes intéressés au développement de nouvelles transformations énantiosélectives combinant les outils modernes de la synthèse organique que sont les « Multiples Bond-Forming Transformations » et l'organocatalyse afin de synthétiser des molécules d'intérêt structural et biologique. Dans ce contexte, nous avons d'abord mis au point deux nouvelles réactions domino initiées par une addition de Michael. La première, une cascade addition de Michael-acylation, permet la synthèse de spiroglutarimides optiquement actifs à partir de β-cétoamides et de nouveaux bis-électrophiles, les cyanures d'acyle α,β-insaturés. La deuxième, une réaction domino addition de Michaelhémiacétalisation- hémiaminalisation, permet la synthèse de d'hétérocycles azotés à sept chaînons à partir d'α-cétoamides comme nouveaux bis-nucléophiles. / This work focused on the development of novel enantioselective transformations combining Multiples Bond-Forming Transformations and organocatalysis which are modern tools of organic synthesis in order to synthetize molecules of structural and biological interests. In this context, we developed two new Michael addition initiated domino reactions. The first one, a domino Michael addition-acylation, allows the synthesis of optically active spiroglutarimides starting from β-ketoamides and α,β-unsaturated acyles cyanides as new biselectrophiles.The second one, a domino Michael addition-hemiaminalizationhemiacetalization, allows the synthesis of seven-membered aza-cycles using α-ketoamides as new bis-nucleophiles.

No description available.

Rhomboid intramembrane serine proteases cleave polypeptide chains within lipid bilayer. Rhomboid proteases were originally discovered in Drosophila melanogaster where they regulate ontogenesis of the fly, but they are present in all domains of life. Nowadays, various diseases, such as malaria, amoebiasis, Parkinson's disease, various tumour malignancies, and diabetes, have been linked with rhomboid proteases. However, natural substrates and function of most rhomboids remain elusive. Cell biology tools are needed for unravelling functions of rhomboids, as well as for potential pharmacological applications, and this together fuels the effort to develop specific rhomboid inhibitors. The inhibitors known to date always bear an electrophilic warhead attacking the nucleophilic serine of the atypical serine-histidine catalytic dyad of rhomboid. From the various developed inhibitors, peptidyl -ketoamides substituted at the ketoamide nitrogen by hydrophobic groups, discovered in our laboratory, hold the biggest potential. They are potent, reversible, selective, tunable, and are built around a pharmacophore already approved for medical use. Here, I set out to improve peptidyl -ketoamides by exploring the chemical space in the active site of rhomboid and testing substituents of the ketoamide nitrogen of increasing...